The bolus group had the longest median infusion duration ( P < 0.001 for both ) but experienced an increase in breakthrough pain incidence ( P = 0.004 ) and intensity ( P = 0.04 vs. basal-bolus group ) as well as sleep disturbances ( P < 0.001 for both ) compared with the other groups .
